3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Liver Neoplasms
1
Hypoxia
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
5
pimonidazole
4
fluoroazomycin arabinoside
4
Radiotherapy
4
Injections
3
Propofol
2
Positron Emission Tomography Computed Tomography
2
Drug Therapy
2
Blood Specimen Collection
2
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fludarabine
1
alovudine
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
Temozolomide
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Saline Solution
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxygen
1
Nitroglycerin
1
NVP-BKM120
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Letrozole
1
Hydroxychloroquine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hypoxia
×
inositol trispyrophosphate
×
Clear all
NCT02528526
2015-08-19
OXY1A
University of Zurich
Phase 1/2
Unknown
69 enrolled